BSE Live
Oct 31, 16:01Prev. Close
642.80
Open Price
644.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 31, 15:58Prev. Close
643.25
Open Price
643.00
Bid Price (Qty.)
640.95 (10)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Rossari Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 11.07 | 11.05 | 11.03 | 11.01 | 10.39 | |
| Total Share Capital | 11.07 | 11.05 | 11.03 | 11.01 | 10.39 | |
| Reserves and Surplus | 1,066.10 | 945.61 | 847.67 | 770.23 | 394.06 | |
| Total Reserves and Surplus | 1,066.10 | 945.61 | 847.67 | 770.23 | 394.06 | |
| Total Shareholders Funds | 1,077.17 | 960.34 | 858.70 | 784.52 | 404.44 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 0.00 | 24.94 | 34.93 | 0.00 | 0.00 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Long Term Liabilities | 16.37 | 10.91 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 3.07 | 1.84 | 2.13 | 1.23 | 0.99 | |
| Total Non-Current Liabilities | 19.43 | 37.69 | 37.06 | 1.23 | 0.99 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 30.14 | 30.11 | 29.98 | 0.00 | 0.00 | |
| Trade Payables | 285.93 | 225.87 | 178.94 | 115.81 | 123.64 | |
| Other Current Liabilities | 34.90 | 24.58 | 20.02 | 23.46 | 14.59 | |
| Short Term Provisions | 3.35 | 2.59 | 0.97 | 0.91 | 0.70 | |
| Total Current Liabilities | 354.32 | 283.14 | 229.91 | 140.18 | 138.93 | |
| Total Capital And Liabilities | 1,450.92 | 1,281.17 | 1,125.67 | 925.93 | 544.36 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 170.99 | 160.19 | 151.62 | 171.96 | 167.03 | |
| Intangible Assets | 8.21 | 7.10 | 3.82 | 5.42 | 3.73 | |
| Capital Work-In-Progress | 34.09 | 24.60 | 10.67 | 0.84 | 0.32 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 213.29 | 191.89 | 169.11 | 178.22 | 171.07 | |
| Non-Current Investments | 493.11 | 490.60 | 472.78 | 371.85 | 9.25 | |
| Deferred Tax Assets [Net] | 6.62 | 4.30 | 2.63 | 1.03 | 0.05 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 39.74 | 26.40 | 10.48 | 6.77 | 24.47 | |
| Total Non-Current Assets | 752.76 | 713.19 | 655.00 | 557.86 | 204.85 | |
| CURRENT ASSETS | ||||||
| Current Investments | 45.29 | 37.56 | 20.31 | 9.01 | 0.00 | |
| Inventories | 178.83 | 151.13 | 112.83 | 107.44 | 88.52 | |
| Trade Receivables | 374.60 | 301.91 | 243.85 | 180.96 | 137.32 | |
| Cash And Cash Equivalents | 16.02 | 25.67 | 80.79 | 34.81 | 85.98 | |
| Short Term Loans And Advances | 35.60 | 24.55 | 0.11 | 2.70 | 2.78 | |
| OtherCurrentAssets | 47.83 | 27.16 | 12.77 | 33.15 | 24.91 | |
| Total Current Assets | 698.16 | 567.98 | 470.67 | 368.07 | 339.51 | |
| Total Assets | 1,450.92 | 1,281.17 | 1,125.67 | 925.93 | 544.36 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 236.48 | 94.11 | 125.56 | 178.26 | 5.13 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 104.12 | 108.01 | 85.65 | 186.25 | 133.59 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 411.88 | 208.43 | 127.22 | 108.43 | 64.52 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 5.28 | 5.28 | 5.28 | 5.28 | 5.28 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 493.11 | 490.60 | 472.78 | 371.85 | 9.25 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | 45.29 | 37.56 | 20.31 | 9.01 | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | 9.01 | -- | 
24.10.2025
16.10.2025
Rossari Consolidated September 2025 Net Sales at Rs 586.11 crore, up 17.61% Y-o-Y
16.10.2025
Rossari Standalone September 2025 Net Sales at Rs 419.51 crore, up 24.86% Y-o-Y
25.07.2025
16.10.2025
Rossari Consolidated September 2025 Net Sales at Rs 586.11 crore, up 17.61% Y-o-Y
16.10.2025
Rossari Standalone September 2025 Net Sales at Rs 419.51 crore, up 24.86% Y-o-Y
21.07.2025
Rossari Consolidated June 2025 Net Sales at Rs 543.72 crore, up 11.04% Y-o-Y
21.07.2025
Rossari Standalone June 2025 Net Sales at Rs 365.76 crore, up 21.63% Y-o-Y